SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that Andy LaFrence, vice president of finance and chief financial officer, will make a presentation to the investment community at the Canaccord Genuity Medical Technology & Diagnostics Conference on Thursday, November 14, 2013, at 1 p.m. CT (2 p.m. ET) in New York City.
A live audio webcast of the presentation will be available by going to the investor relations portion of the Company’s website at www.surmodics.com and clicking on the webcast icon. At the end of the day on Thursday, November 14, the audio and slide presentation will be archived on the Company’s website for 90 days.
About SurModics, Inc.
SurModics’ mission is to exceed our customers’ expectations and enhance the well-being of patients by providing the world’s foremost, innovative surface modification technologies and in vitro diagnostic chemical components. The Company partners with the world’s leading and emerging medical device, diagnostic and life science companies to develop and commercialize innovative products designed to improve patient diagnosis and treatment. Core offerings include surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and microarrays. SurModics is headquartered in Eden Prairie, Minnesota. For more information about the Company, visit www.surmodics.com. The content of SurModics’ website is not part of this press release or part of any filings that the Company makes with the SEC.
|Venaxis to Present at Canaccord Genuity Medical Technology & Diagnostics Forum (2013/11/7)|
|MannKind Corporation to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum ()|
|NeuroMetrix to Present at Canaccord Genuity Medical Technology & Diagnostics Forum ()|
|OraSure Technologies to Present at Canaccord|Genuity's Medical Technology & Diagnostics Forum ()|
|PhotoMedex, Inc. to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum ()|
|ZELTIQ to Present at Canaccord Genuity Medical Technology and Diagnostics Forum (2013/10/31)|
|Vascular Solutions to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum (2013/10/30)|
|MiMedx To Present At Canaccord Genuity Medical Technology And Diagnostics Forum (2013/10/31)|
|iCAD to Participate in the Canaccord Genuity Medical Technology & Diagnostics Forum ()|
|LeMaitre Vascular to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 14, 2013 ()|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.